Skip to main navigation menu Skip to main content Skip to site footer

Genotypification of the MSP3 Gene in patients with complicated Malaria

Genotipificación del gen MSP3 en pacientes con Malaria complicada



How to Cite
Espitia D, Y., Castro C, C., Rodríguez R, V., Causil, L., Velasco P, M. C., Quintero P, G., & Yasnot A, M. F. (2017). Genotypification of the MSP3 Gene in patients with complicated Malaria. Journal Advances in Health, 2(1), 16-25. https://doi.org/10.21897/25394622.1391

Dimensions
PlumX
Yeiner Espitia D
Carlos Castro C
Virginia Rodríguez R
Luis Causil
María Camila Velasco P
Gustavo Quintero P
María Fernanda Yasnot A

Objective. The genetic diversity of the natural populations of Plasmodium vivax parasites was studied by studying the variable region ofthe Pvmsp-3α gene. Materials and methods. PCR-RFLP was performed in 29 samples of patients with P. vivax malaria with complications (PC) and 32 patients with P. vivax malaria with out complications (PNC), all patients from the Bajo-Córdoba-Uraba region, Highly endemicto malaria. Total blood samples were collected for DNA extraction using the saponin /chelex-100 technique. The RFLP technique was used using there striction en zymes HhA Iand AluI. Teneasily distinguis hablere striction patterns were detected after the PCR products were digested with the enzyme Alu I and 9 with the enzyme Hha I. Results. The Pvmsp-3α gene exhibited large polymorphismand the results suggest that this gene can be used in Colombia asa moleculare pidemiological marker for the genotypin go fP. vivax. Further more, the PH1 pattern with the AluIen zyme showed higher frequency in the complicated patients. Conclusions. The Pvmsp3 gene may be agenetic marker of variability in the circulating strain so fP. vivax and the PH1 suggest samarker for predicting a complication in patients with vivax malaria.


Article visits 880 | PDF visits


Downloads

Download data is not yet available.
  1. Ariey F, Hommel D, Le Scanf C, Duchemin JB, Peneau C, Hulin A, et al. Association of severe malaria with a specific Plasmodium falciparum genotype in French Guiana. J Infect Dis 2001, 184(2):237-41.
  2. Arnott A, Barry A, Reeder J. Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination. Malaria Journal 2012, 11:14
  3. Bharti P, Mishra AK, Chand SK, Singh N. “Epidemiology of Malaria in an area of Low Malaria Transmission in Central India.” Abstrat Book. American Society of Tropical Medicine and Hygiene 54th Annual Meeting 2005, 73(6): 125.
  4. Boletín vigilancia de la malaria en Colombia 2-2015 [http:// www2.paho.org/COL/index. php?option=com_docman&task=doc_ download&gi d=1175&Itemid=]
  5. Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, et al. The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc Natl Acad Sci U S A 2008, 105: 16290–16295.
  6. Bruce MC, Galinski MR, Barnwell JW, Snounou G, Day KP. Polymorphism at the merozoite surface protein-3alpha locus of Plasmodium vivax: global and local diversity. Am J Trop Med Hyg 1999; 61: 518-25.
  7. Carmona Fonseca J, Maestre A. Incidencia de la malaria gestacional, congénita y placentaria en Urabá (Antioquia, Colombia), 2005-2007. Rev Colomb Obstet Ginecol 2009, 60:12-26.
  8. Carter R, Mendis KN. Evolutionary and historical aspects of the burden of malaria. Clinical microbiology reviews 2002, 15(4):564-594.
  9. Chaparro P. “Informe final de malaria, semanas 1 a 52 Colombia, 2007.” Informe Quincenal Epidemiológico Nacional 2008; 13(4):49-64).
  10. Cowman AF, Crabb BS. Invasion of red blood cells by malaria parasites. Cell 2006, 124(4):755-766.
  11. Cristiano FA, Pqrez MA, Nicholls RS, Guerra AP. Polymorphism in the Plasmodium vivax msp 3a gene in field samples from Tierralta, Colombia. Mem Inst Oswaldo Cruz 2008; 103: 493-6.
  12. Padilla J, Peña S. Situación epidemiológica de la malaria en Colombia. Informe Quincenal Epidemiológico Nacional 2002; 7(19):333-346.
  13. Polley SD,Tetteh KK, Lloyd JM, Akpogheneta OJ, Greenwood BM, Bojang KA, Conway DJ: Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection. The Journal of infectious diseases 2007, 195(2):279-287.
  14. Prajapati SK, Joshi H, Valecha N. Plasmodium vivax merozoite surface protein-3a: a high- resolution marker for genetic diversity studies. JVector Borne Dis 2010; 47: 85-90.
  15. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM: Vivax malaria: neglected and not benign. The American journal of tropical medicine and hygiene 2007, 77(6 Suppl):79-87.
  16. Puentes A, Garcia J, Ocampo M, Rodriguez L, Vera R, Curtidor H, Lopez R, Suarez J, Valbuena J, Vanegas M et al: P. falciparum: merozoite surface protein-8 peptides bind specifically to human erythrocytes. Peptides 2003, 24(7):1015- 1023.
  17. Puentes A, Ocampo M, Rodriguez LE, Vera R, Valbuena J, Curtidor H, Garcia J, Lopez R, Tovar D, Cortes J et al: Identifying Plasmodium falciparum merozoite surface protein-10 human erythrocyte specific binding regions. Biochimie 2005, 87(5):461-472.
  18. Ribeiro RS, Ladeira L, Rezende aM, Fernandes CJ, Carvalho LH, Ferreira C. analysis of the genetic variability of PvMSP-3 among Plasmodium vivax in Brazilian field isolates. Mem Inst oswaldo Cruz, Rio de Janeiro. 2011; 6:27-33.
  19. Richie TL, Saul A: Progress and challenges for malaria vaccines. Nature 2002, 415(6872):694-701.
  20. Rodriguez-Morales AJ, Delgado L, Martinez N, et al. Impact of imported malaria on the burden of disease in northeastern Venezuela. J Travel Med 2006; 13:15–20.
  21. Roshanravan B, et al. 2003. Endemic malaria in the Peruvian Amazon region of Iquitos. Am. J. Trop. Med. Hyg. 69:45–52.
  22. Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, et al. (2008) The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc Natl Acad Sci U S A 105: 16290–16295.
  23. Bruce MC, Galinski MR, Barnwell JW, Snounou G, Day KP. Polymorphism at the merozoite surface protein-3alpha locus of Plasmodium vivax: global and local diversity. Am J Trop Med Hyg 1999; 61: 518-25.
  24. Carmona Fonseca J, Maestre A. Incidencia de la malaria gestacional, congénita y placentaria en Urabá (Antioquia, Colombia), 2005-2007. Rev Colomb Obstet Ginecol. 60:12-26.
  25. Carter R, Mendis KN: Evolutionary and historical aspects of the burden of malaria. Clinical microbiology reviews 2002, 15(4):564-594.
  26. Cristiano FA, Pqrez MA, Nicholls RS, Guerra AP. Polymorphism in the Plasmodium vivax msp 3a gene in field samples from Tierralta, Colombia. Mem Inst Oswaldo Cruz 2008; 103: 493-6.
  27. Cui L, Mascorro CN, Fan Q, Rzomp KA, et al. Genetic diversity and multiple infections of Plasmodium vivax malaria in western Thailand. Am J Trop Med Hyg 2003; 68: 613-9. de Souza-Neiras WC, de Melo LM, Machado RL: The genetic diversity of Plasmodium vivax--a review. Memorias do Instituto Oswaldo Cruz 2007, 102(3):245-254.
  28. Duarte EC, Gyorkos TW, Pang L, Abrahamowicz M. Epidemiology of malaria in a hypoendemic Brazilian Amazon migrant population: A cohort study. Am J Trop Med Hyg. 2004; 70:229-37.

Sistema OJS 3.4.0.3 - Metabiblioteca |